The BIO-Europe Spring, Europe’s largest springtime digital partnering event, will take place from March 22nd to 25th and allow potential biopharma partners to connect efficiently.
The event will gather about 1500 attendees, more than 990 companies from 41 countries. Networking and partnering opportunities are available with a wide range of business leaders such as senior executives of leading biotech companies, business development teams from pharmaceutical companies, investors and industry experts.
As part of the on-demand “Fireside Chats” stream sessions, our CEO Laurent Levy spoke to moderator Alexandra MacLean, Principal, TVM Capital on “Blockbuster potential – What’s next?”. This chat covers the origin of Nanobiotix, our journey to being Nasdaq-listed and the plans for further development and growth.
Our Business Development team will take part in this event and is looking forward to virtually meet with partners who are interested to find out more about our work. We are available to schedule a meeting at your convenience through the partneringONE platform at BIO-Europe Spring or alternatively contact us via email at BD@nanobiotix.com.
The European Society for Medical Oncology (ESMO) Annual Meeting will be virtual this year from 18th to 22nd September. This conference is the opportunity for medical oncologists and other oncology professionals from the many related fields to come together. Pr. Le Tourneau and Pr. De Baere will be there presenting datas.
